Novel medications inducing adrenal insufficiency

Article metrics

Emerging evidence demonstrates that an increasing number of novel medications have considerable potential to induce adrenal insufficiency. This condition might lead to acute adrenocortical insufficiency, which is potentially fatal; however, the condition could be avoided if clinicians are more aware of the new findings and their implications.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Bornstein, S. R. Predisposing factors for adrenal insufficiency. N. Engl. J. Med. 360, 2328–2339 (2009).

  2. 2.

    Bornstein, S. R. et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice guideline. J. Clin. Endocrinol. Metab 101, 364–389 (2016).

  3. 3.

    Mebrahtu, T. F. et al. Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England. J. Clin. Endocrinol. Metab. https://doi.org/10.1210/jc.2019-00153 (2019).

  4. 4.

    Ferraldeschi, R. et al. Molecular pathways: inhibiting steroid biosynthesis in prostate cancer. Clin. Cancer Res. 19, 3353–3359 (2013).

  5. 5.

    Oksala, R. et al. SUN-LB002 CYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer. J. Endocr. Soc. https://doi.org/10.1210/js.2019-SUN-LB002 (2019).

  6. 6.

    Hofmann, A. et al. Aldosterone synthase inhibition improves glucose tolerance in zucker diabetic fatty (ZDF) rats. Endocrinology 157, 3844–3855 (2016).

  7. 7.

    Tan, M. H. et al. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports. Clin. Diabetes Endocrinol. 5, 1 (2019).

  8. 8.

    Gupta, S. Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders. Vasc. Health Risk Manag. 12, 421–433 (2016).

  9. 9.

    Donegan, D. Opioid induced adrenal insufficiency: what is new? Curr. Opin. Endocrinol. Diabetes Obes. 26, 133–138 (2019).

  10. 10.

    Harvey, P. W. Adrenocortical endocrine disruption. J. Steroid Biochem. Mol. Biol. 155, 199–206 (2016).

Download references

Author information

Correspondence to Stefan R. Bornstein.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark